Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATE OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc. | ex31-2.htm |
| EX-32.1 - CERTIFICATE OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc. | ex32-1.htm |
| EX-31.1 - CERTIFICATE OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc. | ex31-1.htm |
| EX-32.2 - CERTIFICATE OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc. | ex32-2.htm |
| EX-1 - FIRST AMENDMENT TO LEASE - TherapeuticsMD, Inc. | ex10-36.htm |
| EXCEL - IDEA: XBRL DOCUMENT - TherapeuticsMD, Inc. | Financial_Report.xls |
| 10-K - ANNUAL REPORT - TherapeuticsMD, Inc. | txmd-10k_123114.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-185156, 333-186189, 333-193558, 333-197699, 333-201171) on Form S-3 and (No. 333-191730) on Form S-8 of TherapeuticsMD, Inc. of our report dated March 12, 2015, relating to our audits of the consolidated financial statements as of December 31, 2014 and 2013 and for each of the three years in the period ended December 31, 2014, and the effectiveness of internal control over financial reporting as of December 31, 2014, which appear in the Annual Report on Form 10-K of TherapeuticsMD, Inc. for the year ended December 31, 2014.
/s/ Rosenberg Rich Baker Berman & Company
Somerset, NJ
March 12, 2015